Works by Li, Mengyu


Results: 186
    1

    Targeting Drp1 inhibits ESCC progression via the ROS-PGC1-α-Nrf1/2 pathway.

    Published in:
    Journal of Translational Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12967-025-06697-8
    By:
    • Jiang, Zhixiong;
    • Yang, Yating;
    • Zhou, Jinchi;
    • Li, Xin;
    • Meng, Qingqing;
    • Yu, Xiangyi;
    • Xue, Yaxin;
    • Li, Mengyu;
    • Cai, Yichen;
    • Han, Pengchun;
    • Jiang, Mingjun;
    • Wang, Huizhen;
    • Liu, Congrong;
    • Zhao, Jing;
    • Wan, Lixin;
    • Bao, Dengke
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    33
    34
    35
    36
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50